Chemotherapy of ovarian cancer

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

1996 • 2,766 citations

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

1989 • 1,831 citations

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

Principles and Practice of Gynecologic Oncology

1992 • 933 citations

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

1994 • 639 citations

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

1983 • 534 citations

Intraperitoneal Cisplatin with Systemic Thiosulfate Protection

1982 • 494 citations

Creatinine Clearance: Bedside Estimate

1973 • 489 citations

Staging Laparotomy in Early Ovarian Cancer

1983 • 479 citations

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

1991 • 438 citations

Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer

1984 • 398 citations

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

1994 • 379 citations

A Critical Appraisal of the Human Tumor Stem-Cell Assay

1983 • 365 citations

Prospective clinical trial of a human tumor cloning system.

1983 • 340 citations

High-Dose Cisplatin in Hypertonic Saline

1984 • 335 citations

Advanced Ovarian Adenocarcinoma

1978 • 324 citations

Pleiotropic phenotype of colchicine‐resistant CHO cells: Cross‐resistance and collateral sensitivity

1976 • 314 citations

Direct cloning of human ovarian carcinoma cells in agar.

1978 • 305 citations

Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials

1991 • 272 citations

Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.

1980 • 249 citations

Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.

1982 • 218 citations

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.

1996 • 213 citations

Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer

1994 • 193 citations

Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study.

1995 • 190 citations

Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.

1991 • 186 citations

Ovarian carcinoma

1979 • 184 citations

Alterations in the toxicity of cis-Dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration

1981 • 170 citations

IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPY

1980 • 165 citations

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

1992 • 159 citations

Management of Ovarian Carcinoma

1976 • 154 citations

Impact of doxorubicin on survival in advanced ovarian cancer.

1995 • 149 citations

Second-look operations in ovarian cancer

1980 • 149 citations

Review of ovarian cancer at the University of Texas Systems Cancer Center, M. D. Anderson Hospital and Tumor Institute

1979 • 146 citations

The role of adjuvant therapy in Stage I ovarian cancer

1980 • 139 citations

Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.

1982 • 137 citations

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

1996 • 134 citations

Cyclophosphamide Plus Cisplatin Versus Cyclophosphomide, Doxorubicin, and Cisplatin Chemotherapy of Ovarian-carcinoma - a Metaanalysis

1991 • 132 citations

Management of Ovarian Carcinoma

1976 • 121 citations

Cancer Statistics, 1984

1984 • 120 citations

Advanced ovarian cancer correlation of histologic grade with response to therapy and survival

1980 • 116 citations

High volume intraperitoneal chemotherapy (?Belly bath?) for ovarian cancer

1978 • 107 citations

Treatment of Ovarian Carcinoma: Possibilities for Progress

1972 • 107 citations

Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.

1979 • 105 citations

Epithelial carcinoma of the ovary:prognostic importance of histologic grade.

1975 • 105 citations

Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.

1981 • 101 citations

Tamoxifen therapy for advanced ovarian cancer.

1982 • 100 citations

Paclitaxel Delivered as a 3-hr Infusion with Cisplatin in Patients with Gynecologic Cancers: Unexpected Incidence of Neurotoxicity

1996 • 98 citations

Chemotherapy of ovarian cancer. New Approaches to Treatment

1972 • 92 citations

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

1996 • 88 citations

Second trial drugs in ovarian cancer

1977 • 88 citations

High-dose platinum for the treatment of refractory ovarian cancer

1981 • 84 citations

Choice of postoperative therapy based on prognostic factors

1982 • 83 citations

Müllerian Duct Regression in the Embryo Correlated with Cytotoxic Activity Against Human Ovarian Cancer

1979 • 82 citations

Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy.

1983 • 71 citations

The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).

1979 • 71 citations

Carboplatin versus cisplatin

1993 • 68 citations

Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma

1985 • 67 citations

USE OF HIGH DOSE CIS‐DICHLORODIAMMINE PLATINUM (II) (NSC—119875)^† FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARY

1981 • 64 citations

Advanced ovarian carcinoma: Response to antiestrogen therapy

1981 • 63 citations

Malignant Tumors of the Ovary Managed with Postoperative Megavoltage Irradiation

1969 • 63 citations

Second-look laparotomy in the management of gynecologic malignancy

1982 • 63 citations

Mullerian Inhibiting Substance Inhibits Growth of a Human Ovarian Cancer in Nude Mice

1981 • 60 citations

The chemotherapy of ovarian carcinoma

1974 • 58 citations

The multimodal approach to the treatment of stage III ovarian carcinoma

1982 • 57 citations

Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)

1981 • 53 citations

Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma

1980 • 47 citations

Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.

1996 • 47 citations

Gouty Arthritis and Polycystic Kidney Disease

1973 • 46 citations

Histologic grade in advanced ovarian cancer.

1979 • 40 citations

Ovarian cancer, Part II: Treatment

1992 • 38 citations

Editorials: OVARIAN CANCER WITH SPECIAL REGARD TO RADIOTHERAPY

1971 • 32 citations

Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.

1978 • 30 citations

Progestin therapy for advanced ovarian cancer: a phase II Eastern Cooperative Oncology Group trial.

1981 • 27 citations

Dose intensity in advanced ovarian cancer: have we answered the question?

1995 • 23 citations

Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.

1979 • 22 citations

The impact of mammography on breast cancer detection

1993 • 20 citations

Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.

1979 • 18 citations

Pneumothorax after fine needle aspiration of the breast

1991 • 13 citations

Radiation therapy in the management of carcinoma of the ovary.

1975 • 11 citations

Direct Cloning of Human Ovarian Cancer in Soft Agar: Clinical Limitations and Pharmacologic Applications

1984 • 10 citations

PREOPERATIVE IRRADIATION IN STAGE III CARCINOMA OF THE OVARY

1977 • 7 citations

[Treatment of ovarian cancer].

1958 • 5 citations

Phase II Trial of Navelbine in Advanced Epithelial Ovarian Cancer

1997 • 5 citations